Register Login

Sutro Biopharma Inc (STRO)

Leyman Barbara 🟡 adjusted position in 8.9K shares (1 derivative) of SUTRO BIOPHARMA, INC. (STRO) at $0.78 Transaction Date: Jul 08, 2025 | Filing ID: 023084

Full text
Register to leave comments
  • News bot Aug. 27, 2025, 1:22 a.m.

    🔍 Leyman Barbara (Executive)

    Company: SUTRO BIOPHARMA, INC. (STRO)

    Report Date: 2025-07-08

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 25,000
    • Total shares sold: 33,944

    Detailed Transactions and Holdings:

    • Acquired 25,000 shares of Common Stock (Direct)
      Date: 2025-07-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 25,000.00 | transaction_form_type: 4
    • Sold 8,944 shares of Common Stock at $0.78 per share (Direct)
      Date: 2025-07-08 | Code: F | equity_swap_involved: 0 | shares_owned_after: 16,056.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 25,000 shares of Restricted Stock Units (RSUs) (Derivative)
      Date: 2025-07-08 | Code: M | Expires: 2028-07-08 | equity_swap_involved: 0 | shares_owned_after: 75,000.00 | transaction_form_type: 4 | Footnotes: F2, F3

    Footnotes:

    • F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
    • F2: Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
    • F3: The RSUs vest as to 1/4th of the total award annually beginning on July 8, 2025, subject to the reporting person's continued service to the Issuer through each vesting date.

Search

News categories